Tourmaline Bio (TRML) Institutional Ownership $20.65 +0.31 (+1.52%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Tourmaline Bio (NASDAQ:TRML)CurrentInstitutional OwnershipPercentage91.89%Number ofInstitutional Buyers(last 12 months)43TotalInstitutional Inflows(last 12 months)$212.01MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$7.93M Get TRML Insider Trade Alerts Want to know when executives and insiders are buying or selling Tourmaline Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TRML Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Tourmaline Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC31,833$819K0.0%+283.7%0.124% 11/16/2024 Geode Capital Management LLC482,078$12.40M0.0%+6.4%1.880% 11/15/2024 Barclays PLC31,833$819K0.0%+283.7%0.124% 11/15/2024 Jane Street Group LLC21,705$558K0.0%-211.3%0.085% 11/15/2024 Wellington Management Group LLP65,741$1.69M0.0%+72.8%0.256% 11/15/2024 State Street Corp411,980$10.59M0.0%+25.6%1.607% Get the Latest News and Ratings for TRML and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tourmaline Bio and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 Point72 Asset Management L.P.338,437$8.70M0.0%N/A1.320% 11/14/2024 Acuta Capital Partners LLC332,095$8.54M6.9%+23.2%1.295% 11/14/2024 MetLife Investment Management LLC13,886$357K0.0%N/A0.054% 11/13/2024 BNP Paribas Financial Markets13,348$343K0.0%-7.8%0.052% 11/13/2024 FMR LLC15,063$387K0.0%-93.6%0.059% 11/13/2024 The Manufacturers Life Insurance Company8,804$226K0.0%N/A0.034% 11/12/2024 Charles Schwab Investment Management Inc.63,571$1.63M0.0%+3.5%0.248% 11/8/2024 Jennison Associates LLC1,151,973$29.62M0.0%+2.2%4.493% 11/7/2024 Quest Partners LLC9,381$241K0.0%+145.4%0.037% 10/30/2024 AlphaCentric Advisors LLC5,500$141K0.1%-92.7%0.021% 10/25/2024 China Universal Asset Management Co. Ltd.4,932$127K0.0%+63.7%0.019% 9/16/2024 Cubist Systematic Strategies LLC37,861$487K0.0%N/A0.148% 8/16/2024 Algert Global LLC39,866$513K0.0%+122.7%0.155% 8/15/2024 Blue Owl Capital Holdings LP1,715,401$22.06M6.2%+18.5%6.689% 8/14/2024 Cubist Systematic Strategies LLC37,861$487K0.0%N/A0.148% 8/14/2024 Marshall Wace LLP170,447$2.19M0.0%+22.3%0.665% 8/14/2024 HighVista Strategies LLC83,397$1.07M0.4%+57.2%0.325% 8/9/2024 Renaissance Technologies LLC100,076$1.29M0.0%+184.9%0.390% 8/6/2024 Quest Partners LLC3,822$49K0.0%+134.0%0.015% 8/1/2024 Rhumbline Advisers33,239$427K0.0%+28,554.3%0.130% 7/26/2024 Bank of New York Mellon Corp70,697$909K0.0%N/A0.276% 7/26/2024 AlphaCentric Advisors LLC75,000$964K0.7%+22.7%0.292% 7/12/2024 SG Americas Securities LLC33,666$433K0.0%N/A0.131% 5/17/2024 Artal Group S.A.314,496$7.20M0.2%+244.0%1.226% 5/16/2024 California State Teachers Retirement System14,578$334K0.0%N/A0.057% 5/16/2024 Janus Henderson Group PLC11,593$266K0.0%N/A0.045% 5/15/2024 Darwin Global Management Ltd.465,000$10.65M1.4%N/A1.813% 5/15/2024 Avoro Capital Advisors LLC2,222,222$50.89M0.6%+155.9%8.664% 5/15/2024 Altitude Crest Partners Inc.47,400$1.09M0.5%N/A0.185% 5/15/2024 Affinity Asset Advisors LLC50,000$1.15M0.1%-26.6%0.195% 5/14/2024 Qiming U.S. Ventures Management LLC741,691$16.99M18.9%+15.6%2.892% 5/14/2024 Nan Fung Group Holdings Ltd20,987$481K0.4%N/A0.082% 5/14/2024 StemPoint Capital LP274,219$6.28M1.7%N/A1.069% 5/10/2024 Vanguard Group Inc.914,519$20.94M0.0%+19.7%3.566% Did You See Trump’s Bombshell Exec. Order 001? (Ad)Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. 5/7/2024 Swiss National Bank32,000$733K0.0%N/A0.125% 5/2/2024 Jennison Associates LLC1,115,251$25.54M0.0%N/A4.348% 5/1/2024 BNP Paribas Financial Markets1,346$31K0.0%N/A0.005% 4/29/2024 China Universal Asset Management Co. Ltd.4,939$113K0.0%+109.5%0.019% 4/19/2024 Denali Advisors LLC5,600$128K0.0%N/A0.022% 2/15/2024 Great Point Partners LLC672,885$17.62M3.0%N/A3.308% 2/14/2024 Braidwell LP906,820$23.74M0.9%N/A4.458% 2/14/2024 Avoro Capital Advisors LLC868,407$22.74M0.3%N/A4.269% 2/14/2024 RTW Investments LP398,850$10.44M0.2%N/A1.961% 2/13/2024 Affinity Asset Advisors LLC68,081$1.78M0.3%N/A0.335% 2/7/2024 Jump Financial LLC14,500$380K0.0%N/A0.071% 2/7/2024 Vivo Capital LLC591,882$15.50M1.3%N/A2.910% 1/30/2024 BML Capital Management LLC245,500$6.43M4.9%N/A1.207% (Data available from 1/1/2016 forward) TRML Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TRML shares? During the previous two years, 44 institutional investors and hedge funds held shares of Tourmaline Bio. The most heavily invested institutionals were Avoro Capital Advisors LLC ($50.89M), Jennison Associates LLC ($29.62M), Braidwell LP ($23.74M), Blue Owl Capital Holdings LP ($22.06M), Vanguard Group Inc. ($20.94M), Great Point Partners LLC ($17.62M), and Qiming U.S. Ventures Management LLC ($16.99M).Learn more on TRML's institutional investors. What percentage of Tourmaline Bio stock is owned by institutional investors? 91.89% of Tourmaline Bio stock is owned by institutional investors. Learn more on TRML's institutional investor holdings. Which institutional investors have been buying Tourmaline Bio stock? Of the 43 institutional investors that purchased Tourmaline Bio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Avoro Capital Advisors LLC ($2.22M), Jennison Associates LLC ($1.14M), Braidwell LP ($906.82K), Great Point Partners LLC ($672.89K), Vivo Capital LLC ($591.88K), Darwin Global Management Ltd. ($465K), and RTW Investments LP ($398.85K). How much institutional buying is happening at Tourmaline Bio? Institutional investors have bought a total of 8,917,173 shares in the last 24 months. This purchase volume represents approximately $212.01M in transactions. Which Tourmaline Bio major shareholders have been selling company stock? The following institutional investors have sold Tourmaline Bio stock in the last 24 months: FMR LLC ($221.67K), AlphaCentric Advisors LLC ($69.50K), Affinity Asset Advisors LLC ($18.08K), and BNP Paribas Financial Markets ($1.13K). How much institutional selling is happening at Tourmaline Bio? Institutional investors have sold a total of 310,378 shares in the last 24 months. This volume of shares sold represents approximately $7.93M in transactions. Related Companies NewAmsterdam Pharma Major Shareholders IDEAYA Biosciences Major Shareholders Centessa Pharmaceuticals Major Shareholders Recursion Pharmaceuticals Major Shareholders Apogee Therapeutics Major Shareholders ImmunityBio Major Shareholders Wave Life Sciences Major Shareholders Mirum Pharmaceuticals Major Shareholders Akero Therapeutics Major Shareholders Tarsus Pharmaceuticals Major Shareholders This page (NASDAQ:TRML) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tourmaline Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tourmaline Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.